Dr. Vogel to Lead Joint Breast Cancer Program

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 3
Volume 5
Issue 3

PITTSBURGH--Victor Vogel, MD, MHS, will lead a newly established joint breast cancer program of the University of Pittsburgh Cancer Institute and Magee-Womens Hospital. He will also join the University of Pittsburgh as professor of medicine and epidemiology.

PITTSBURGH--Victor Vogel, MD, MHS, will lead a newly establishedjoint breast cancer program of the University of Pittsburgh CancerInstitute and Magee-Womens Hospital. He will also join the Universityof Pittsburgh as professor of medicine and epidemiology.

Dr. Vogel comes to Pittsburgh from the University of Texas M.D.Anderson Cancer Center, where he was responsible for recruitingthe largest number of women onto the Breast Cancer PreventionTrial, the national study designed to determine the value of tamoxifen(Nolva-dex) in preventing breast cancer in high-risk women.

"One of the program's most important missions," Dr.Vogel said, "will be to enhance delivery of care to womenwho face barriers, ie, older women or those who are poor or livein rural areas."

Related Videos
Pegulicianine-guided breast cancer surgery may allow practices to de-escalate subsequent radiotherapy, says Barbara Smith, MD, PhD.
Barbara Smith, MD, PhD, spoke about the potential use of pegulicianine-guided breast cancer surgery based on reports from the phase 3 INSITE trial.
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey K. Anders, MD, an expert on breast cancer
A panel of 4 experts on breast cancer seated at a long table
A panel of 4 experts on breast cancer seated at a long table